Autolus Therapeutics PLC (NAS:AUTL)
$ 3.86 -0.04 (-1.03%) Market Cap: 1.03 Bil Enterprise Value: 330.35 Mil PE Ratio: 0 PB Ratio: 1.76 GF Score: 59/100

Q1 2022 Autolus Therapeutics PLC Earnings Call Transcript

May 05, 2022 / 12:30PM GMT
Release Date Price: $3.26 (+1.56%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Autolus Therapeutics First Quarter 2022 Financial Results conference call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Olivia Manser, Director of Investor Relations. Please go ahead ma'am.

Olivia Manser;Autolus Ltd.;Director
Investor Relations,

Thank you, and Good morning or good afternoon everyone, and thank you for joining us to take part in today's call on the Operational Highlights and Financial Results for the first quarter of 2022. I am Olivia Manser, Director of Investor Relations, and with me today are Dr. Christian Itin, our Chief Executive Officer, and Dr. Lucinda Crabtree, our Chief Financial Officer.

Before we begin, I would like to remind you that during today's call our discussion will contain forward looking statements. Please make sure you're familiar with our disclaimer, which is on Slide 2 of the presentation. On Slide 3, you will see the agenda for today, which is as follows:

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot